Journal of Community Health

, Volume 37, Issue 6, pp 1136–1144 | Cite as

Low HPV Vaccine Coverage Among Female Community College Students

Original Paper


This study assessed HPV vaccination and its correlates among culturally diverse 18–26 year-old community college women in Los Angeles. Specific research questions were: (1) What proportion of respondents have initiated the HPV vaccine, and what proportion have completed the three-dose series? (2) What demographic (e.g., age, ethnicity), psychosocial (e.g., vaccine-related beliefs, perceived social norms), and health care-related variables (e.g., health insurance status, provider recommendation, health care trust and satisfaction) are associated with vaccine initiation for this sample? Participants were recruited from the campus of a community college in central Los Angeles. All female students between 18 and 26 were eligible to participate. An anonymous web-based survey assessed number of HPV vaccine doses received as well as demographic information, HPV- and HPV vaccine-related knowledge, attitudes, and behavior, perceived social norms, provider & health care system factors, sexual behavior, cervical health, and mother-daughter communication about sex. Analyses were conducted using 178 surveys. Multivariate logistic regression tested the relationships of statistically significant bivariate predictors to vaccine initiation. Those who initiated the vaccine were younger, more often had a health-related academic major, thought the vaccine to be safer, perceived HPV severity lower, and perceived higher social approval for HPV vaccination than those unvaccinated. All who had initiated the vaccine had a doctor’s recommendation. To increase uptake among 18–26-year-old women, research should explore provider interventions to increase vaccine recommendation, and also identify individuals and groups who may have negative beliefs about vaccine safety and efficacy to provide support in vaccine decision-making.


HPV vaccine Cervical cancer prevention College women Community college Ethnic minority women 



This research was supported by the UCLA Cancer Education and Career Development Program, NCI Grant R25 CA 87949. The authors also wish to thank the staff and students of the Los Angeles Community College District, who made this research possible.


  1. 1.
    Romanowski, B., de Borba, P. C., Naud, P. S., et al. (2009). Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: Analysis of a randomized placebo-controlled trial up to 6.4 years. Lancet, 374, 1975–1985.PubMedCrossRefGoogle Scholar
  2. 2.
    Villa, L. L., Costa, R. L. R., Petta, C. A., et al. (2006). High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. British Journal of Cancer, 95, 1459–1466.PubMedCrossRefGoogle Scholar
  3. 3.
    CDC. (2011). Recommended adult immunization schedule—United States, 2011. MMWR, 60(4), 1–4.Google Scholar
  4. 4.
    CDC. (2012). Adult vaccination coverage—United States, 2010. MMWR, 61(4), 66–72.Google Scholar
  5. 5.
    Chao, C., Velicer, C., Slezak, J., & Jacobsen, S. (2010). Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology, 171, 357–367.PubMedCrossRefGoogle Scholar
  6. 6.
    Dempsey, A., Cohn, L., Dalton, V., & Ruffin, M. (2011). Worsening disparities in HPV vaccine utilization among 19–26 year old women. Vaccine, 29(3), 528–534.PubMedCrossRefGoogle Scholar
  7. 7.
    Licht, A. S., Murphy, J. M., Hyland, A. J., Fix, B. V., Hawk, L. W., & Mahoney, M. C. (2010). Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception? Sexually Transmitted Infection, 86, 74–78.CrossRefGoogle Scholar
  8. 8.
    Chandra, A., Mosher, W. D., Copen, C., & Sionean, C. (2011). Sexual behavior, sexual attraction, and sexual identity in the United States: Data from the 2006–2008 National Survey of Family Growth. National Health Statistics Reports, 36, 1–28.PubMedGoogle Scholar
  9. 9.
    Paavonen, J. (2010). At what age should we be vaccinating for human papillomavirus? Gynecologic and Obstetric Investigation, 70, 233–236.PubMedCrossRefGoogle Scholar
  10. 10.
    Bynum, S. A., Brandt, H. M., Sharpe, P. A., Williams, M. S., & Kerr, J. C. (2011). Working to close the gap: Identifying predictors of HPV vaccine uptake among young African American women. Journal of Health Care for the Poor and Underserved, 22, 549–561.PubMedCrossRefGoogle Scholar
  11. 11.
    Rosenthal, S. L., Weiss, T. W., Zimet, G. D., Ma, L., Good, M. B., & Vichnin, M. D. (2011). Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician’s recommendation. Vaccine, 29, 890–895.PubMedCrossRefGoogle Scholar
  12. 12.
    Roberts, M., Gerrard, M., Reimer, R., & Gibbons, F. (2010). Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics, 125(5), 982–989.PubMedCrossRefGoogle Scholar
  13. 13.
    Tiro, J. A., Tsui, J., Bauer, H. M., Yamada, E., Kobrin, S., & Breen, N. (2012). Uptake and correlates of the human papillomavirus vaccine among adolescent girls and young adult women: An analysis of the 2007 California Health Interview Survey. Journal of Women’s Health, 21, 1–10.CrossRefGoogle Scholar
  14. 14.
    Los Angeles Community College District. (2011). Research and statistics: Student characteristics.
  15. 15.
    Bastani, R., Glenn, B. A., Taylor, V. M., Chen, M. S., Nguyen, T. T., Stewart, S. L., et al. (2010). Integrating theory into community interventions to reduce liver cancer disparities: The Health Behavior Framework. Preventive Medicine, 50, 63–67.PubMedCrossRefGoogle Scholar
  16. 16.
    Allen, J., Othus, M., Shelton, R. C., Li, Y., Norman, N., Tom, L., et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers and Prevention, 19(9), 2187–2198.PubMedCrossRefGoogle Scholar
  17. 17.
    Bastani, R., Glenn, B., Tsui, J., Chang, C., Marchand, E., Taylor, V., et al. (2011). Understanding sub-optimal HPV vaccine uptake among ethnic minority girls. Cancer Epidemiology, Biomarkers and Prevention, 20, 1463–1472.PubMedCrossRefGoogle Scholar
  18. 18.
    Metzler, C. W., Noell, J., & Biglan, A. (1992). The validation of a construct of high-risk sexual behavior in heterosexual adolescents. Journal of Adolescent Research, 7(2), 233–249.CrossRefGoogle Scholar
  19. 19.
    Safran, D. G., Kosinski, M., Tarlov, A. R., Rogers, W. H., Taira, D. A., Lieberman, N., et al. (1998). The Primary Care Assessment Survey: Tests of data quality and measurement performance. Medical Care, 36(5), 728–739.PubMedCrossRefGoogle Scholar
  20. 20.
    Lau, M., Lin, H., & Flores, G. (2012). Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in U.S. adolescent females: 2007 National Survey of Children’s Health. Vaccine, 30, 3112–3118.PubMedCrossRefGoogle Scholar
  21. 21.
    Gee, J., Naleway, A., Shul, I., et al. (2011). Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink. Vaccine, 29, 8279–8284.PubMedCrossRefGoogle Scholar
  22. 22.
    Haupt, R. M., & Sings, H. L. (2011). The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine Gardasil. Journal of Adolescent Health, 49, 467–475.PubMedCrossRefGoogle Scholar
  23. 23.
    Stupiansky, N. W., Zimet, G. D., Cummings, T., Fortenberry, J. D., & Shew, M. (2012). Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. Journal of Adolescent Health, 50, 103–105.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Erica Marchand
    • 1
  • Beth A. Glenn
    • 1
  • Roshan Bastani
    • 1
  1. 1.UCLA Center for Cancer Prevention and Control ResearchSchool of Public HealthLos AngelesUSA

Personalised recommendations